BLX Bladex
Bladex earnings company data as of 4:46 AM ET 10/8
Limited consensus data for this ticker (thin coverage or data-plan limits).
Dates may be company-announced rather than sell-side consensus.
Calendar and recent prints remain the primary lens when available.
Scheduled
1 period, newest first, nothing reported yet. Each row shows EPS above revenue.
| Period | Date | Metric | Estimate | Actual | Result |
|---|---|---|---|---|---|
| FY2026 Q3 | 27 Oct | EPS | — | — | — |
| Rev | — | — | — |
Insider trades
Open-market buys and sales by BLX's executives, directors and 10% owners in the last 12 months, from their Form 4s
- $178K bought by 2 insiders
- None no sales outside a trading plan
- None no planned (10b5-1) sales
-
Annette Marie Van Hoorde CFOBuy$80K 1,454 shares at $55.00 +6.7% to stakeTraded Aug 28 Filed Aug 31
-
Alejandro Horacio Tizzoni Chief Risk OfficerBuy$98K 1,850 shares at $53.00 +2.4% to stakeTraded Aug 21 Filed Aug 24
Also filed in the last 12 months, not counted as buying or selling: 1 other transaction.
SEC filings
Recent issuer filings from EDGAR, 25 shown.
| Filed | Form | Detail | Links |
|---|---|---|---|
| 6-K | Filing Doc | ||
| 6-K | Filing Doc | ||
| 6-K | Filing Doc | ||
| 6-K | Filing Doc | ||
| 6-K | Filing Doc | ||
| 6-K | Filing Doc | ||
| 6-K | Filing Doc | ||
| 6-K | Filing Doc | ||
| 6-K | Filing Doc | ||
| 6-K | Filing Doc | ||
| 6-K | Filing Doc | ||
| 20-F | Filing Doc | ||
| 6-K | Filing Doc | ||
| 6-K | Filing Doc | ||
| 6-K | Filing Doc | ||
| 6-K | Filing Doc | ||
| SCHEDULE 13G/A | — | Filing Doc | |
| 6-K | Filing Doc | ||
| SCHEDULE 13G | — | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| 6-K | Filing Doc | ||
| 6-K | Filing Doc | ||
| 6-K | Filing Doc | ||
| SCHEDULE 13G/A | — | Filing Doc | |
| 6-K | Filing Doc |
No filings match this filter.
Estimates are consensus figures; SEC filings remain the official record. Not investment advice.